219 related articles for article (PubMed ID: 28672215)
1. Silymarin impacts on immune system as an immunomodulator: One key for many locks.
Esmaeil N; Anaraki SB; Gharagozloo M; Moayedi B
Int Immunopharmacol; 2017 Sep; 50():194-201. PubMed ID: 28672215
[TBL] [Abstract][Full Text] [Related]
2. Silymarin and Its Role in Chronic Diseases.
Neha ; Jaggi AS; Singh N
Adv Exp Med Biol; 2016; 929():25-44. PubMed ID: 27771919
[TBL] [Abstract][Full Text] [Related]
3. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
[TBL] [Abstract][Full Text] [Related]
4. Silybin and silymarin--new and emerging applications in medicine.
Gazák R; Walterová D; Kren V
Curr Med Chem; 2007; 14(3):315-38. PubMed ID: 17305535
[TBL] [Abstract][Full Text] [Related]
5. Identification of hepatoprotective flavonolignans from silymarin.
Polyak SJ; Morishima C; Lohmann V; Pal S; Lee DY; Liu Y; Graf TN; Oberlies NH
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5995-9. PubMed ID: 20231449
[TBL] [Abstract][Full Text] [Related]
6. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
Mastron JK; Siveen KS; Sethi G; Bishayee A
Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
[TBL] [Abstract][Full Text] [Related]
7. Physiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: III. Silymarin inhibits T-lymphocyte function at low doses but stimulates inflammatory processes at high doses.
Johnson VJ; He Q; Osuchowski MF; Sharma RP
Planta Med; 2003 Jan; 69(1):44-9. PubMed ID: 12567278
[TBL] [Abstract][Full Text] [Related]
8. Silymarin: not just another antioxidant.
Camini FC; Costa DC
J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32134732
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin.
Polyak SJ; Morishima C; Shuhart MC; Wang CC; Liu Y; Lee DY
Gastroenterology; 2007 May; 132(5):1925-36. PubMed ID: 17484885
[TBL] [Abstract][Full Text] [Related]
10. Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (Review).
Katiyar SK
Int J Oncol; 2005 Jan; 26(1):169-76. PubMed ID: 15586237
[TBL] [Abstract][Full Text] [Related]
11. Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling.
Lovelace ES; Wagoner J; MacDonald J; Bammler T; Bruckner J; Brownell J; Beyer RP; Zink EM; Kim YM; Kyle JE; Webb-Robertson BJ; Waters KM; Metz TO; Farin F; Oberlies NH; Polyak SJ
J Nat Prod; 2015 Aug; 78(8):1990-2000. PubMed ID: 26186142
[TBL] [Abstract][Full Text] [Related]
12. Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases.
Gharagozloo M; Javid EN; Rezaei A; Mousavizadeh K
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):251-6. PubMed ID: 23121838
[TBL] [Abstract][Full Text] [Related]
13. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
Federico A; Dallio M; Loguercio C
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
[TBL] [Abstract][Full Text] [Related]
14. Milk thistle in liver diseases: past, present, future.
Abenavoli L; Capasso R; Milic N; Capasso F
Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
[TBL] [Abstract][Full Text] [Related]
15. Extraction, Chemical Composition, Antioxidant Property, and In-vitro Anticancer Activity of Silymarin from Silybum marianum on Kb and A549 Cell Lines.
Azadpour M; Farajollahi MM; Varzi AM; Hashemzadeh P; Mahmoudvand H; Barati M
Curr Drug Discov Technol; 2021; 18(4):511-517. PubMed ID: 32860361
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Insights into the Pharmacological Significance of Silymarin.
Wadhwa K; Pahwa R; Kumar M; Kumar S; Sharma PC; Singh G; Verma R; Mittal V; Singh I; Kaushik D; Jeandet P
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014565
[TBL] [Abstract][Full Text] [Related]
17. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
[TBL] [Abstract][Full Text] [Related]
18. Interactive Effects of Light and Melatonin on Biosynthesis of Silymarin and Anti-Inflammatory Potential in Callus Cultures of
Shah M; Ullah MA; Drouet S; Younas M; Tungmunnithum D; Giglioli-Guivarc'h N; Hano C; Abbasi BH
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934786
[No Abstract] [Full Text] [Related]
19. Efficacy and Mechanisms of
Ghahfarrokhi SH; Heidari-Soureshjani S; Sherwin CMT; Azadegan-Dehkordi Z
Curr Rheumatol Rev; 2024; 20(4):414-425. PubMed ID: 38314596
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effects of Silymarin After the Discontinuation of CCl4-Induced Liver Fibrosis.
Clichici S; Olteanu D; Filip A; Nagy AL; Oros A; Mircea PA
J Med Food; 2016 Aug; 19(8):789-97. PubMed ID: 27441792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
